CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2022; 26(04): e630-e635
DOI: 10.1055/s-0041-1741437
Original Research

Selective Neck Dissection for Node-Positive Oral Cavity Squamous Cell Carcinoma: A Retrospective Cohort Study

1   ENT Department, Peterborough City Hospital, Northwest Anglia NHS Foundation Trust, Peterborough, England
,
2   Department of ENT, Aga Khan University Hospital, Karachi, Sindh, Pakistan
,
3   Department of ENT and Head and Neck Surgery, Patel Hospital, Karachi, Sindh, Pakistan
,
4   Department of Orthopedics, Aga Khan University Hospital, Karachi, Sindh, Pakistan
,
3   Department of ENT and Head and Neck Surgery, Patel Hospital, Karachi, Sindh, Pakistan
,
Atif Hafeez Siddique
5   Department of Otolaryngology, Dow University of Health Sciences, Karachi, Sindh, Pakistan
,
6   Department of Pathology and Laboratory of Medicine, Aga Khan University Hospital, Karachi, Sindh, Pakistan
,
7   Department of General Surgery, Patel Hospital, Karachi, Sindh, Pakistan
› Author Affiliations

Abstract

Introduction Selective neck dissection in clinically node-negative neck is considered the standard of care for oral squamous cell carcinomas (SCCs). Controversy still prevails in node-positive disease regarding the extent of neck dissection. In our part of the world, comprehensive neck dissection is mostly considered to be the minimal optimal treatment for palpable neck disease.

Objective To compare regional control and disease-specific survival between clinically node-positive and node-negative patients undergoing selective neck dissection for oral SCC.

Methods This was a retrospective cohort study conducted in the department of ENT, Head and Neck surgery at a tertiary care hospital. All patients with biopsy-proven oral and lip SCC, with or without nodal disease, who underwent selective neck dissection between April 2006 and July 2015 were included in the study.

Results During the study period, 111 patients with oral SCC underwent selective neck dissection, of whom 71 (62%) were clinically node-negative and 40 (38%) patients had clinically positive nodes in the neck. The mean follow-up was 16.62 months (standard deviation [SD]: 17.03). The overall regional control rates were 95 versus 96% for clinical negative versus positive nodes, respectively (p = 0.589). The disease-specific survival was 84.5% in the node negative group versus 82.5% in the node-positive group (p = 0.703).

Conclusion Selective neck dissection in node-positive neck oral SCC has similar regional control rates when compared with node-negative neck SCC. The difference in disease-specific survival between the two groups is also not significant.



Publication History

Received: 01 June 2020

Accepted: 04 February 2021

Article published online:
22 February 2022

© 2022. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Cancer Registry and Clinical Data Management (CRCDM)—Shaukat Khanum Memorial Cancer Hospital and Research Center (SKMCH & RC)—Report Based on Cancer Cases Registered at SKMCH & RC from December 1994–December 2019 and in 2019 [Internet]. 2020
  • 2 García-Martín JM, Varela-Centelles P, González M, Seoane-Romero JM, Seoane J, García-Pola MJ. Epidemiology of oral cancer. Oral Cancer Detection. Springer; 2019: 81-93
  • 3 Ayaz B, Saleem K, Azim W, Shaikh A. A clinico-pathological study of oral cancers. Biomedica 2011; 27 (01) 29-32
  • 4 Noguti J, De Moura CFG, De Jesus GPP. et al. Metastasis from oral cancer: an overview. Cancer Genomics Proteomics 2012; 9 (05) 329-335
  • 5 Shaha AR. Neck dissection: an operation in evolution. World J Surg Oncol 2005; 3 (01) 22
  • 6 Pantvaidya G, Rao K, D'Cruz A. Management of the neck in oral cancers. Oral Oncol 2020; 100: 104476
  • 7 De Cicco C, Trifirò G, Calabrese L. et al. Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept. Eur J Nucl Med Mol Imaging 2006; 33 (08) 900-905
  • 8 Henriques V, Breda E, Monteiro E. Discrepancy between clinical and pathological neck staging in oral cavity carcinomas. Acta Otorrinolaringol Esp (Engl Ed) 2018; 69 (02) 67-73
  • 9 Kuntz AL, Weymuller Jr EA. Impact of neck dissection on quality of life. Laryngoscope 1999; 109 (08) 1334-1338
  • 10 Gane EM, McPhail SM, Hatton AL, Panizza BJ, O'Leary SP. The relationship between physical impairments, quality of life and disability of the neck and upper limb in patients following neck dissection. J Cancer Surviv 2018; 12 (05) 619-631
  • 11 Shimura S, Ogi K, Miyazaki A. et al. Selective neck dissection and survival in pathologically node-positive oral squamous cell carcinoma. Cancers (Basel) 2019; 11 (02) 269
  • 12 Kakei Y, Komatsu H, Minamikawa T. et al. Extent of neck dissection for patients with clinical N1 oral cancer. Int J Clin Oncol 2020; 25 (06) 1067-1071
  • 13 Kolli VR, Datta RV, Orner JB, Hicks Jr WL, Loree TR. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg 2000; 126 (03) 413-416
  • 14 Liang L, Zhang T, Kong Q, Liang J, Liao G. A meta-analysis on selective versus comprehensive neck dissection in oral squamous cell carcinoma patients with clinically node-positive neck. Oral Oncol 2015; 51 (12) 1076-1081
  • 15 Rodrigo JP, Grilli G, Shah JP. et al. Selective neck dissection in surgically treated head and neck squamous cell carcinoma patients with a clinically positive neck: Systematic review. Eur J Surg Oncol 2018; 44 (04) 395-403
  • 16 Deo SV, Shukla NK, Jha D, Khanna P, Pandit A, Thulkar S. Are we over-treating neck in buccal & alveolo-buccal cancers: experience from a tertiary cancer care center. Indian J Surg Oncol 2012; 3 (04) 272-275
  • 17 Iqbal M, Subhan A, Aslam A. Papillary thyroid carcinoma with tuberculous cervical lymphadenopathy mimicking metastasis. J Coll Physicians Surg Pak 2011; 21 (04) 207-209
  • 18 Ehsan-ul-Haq M, Warraich RA, Abid H, Sajid MAH. Cervical lymph node metastases in squamous cell carcinoma of tongue and floor of mouth. J Coll Physicians Surg Pak 2011; 21 (01) 55-56
  • 19 SHAIKH AA. Shafique S, Shafi M, Punjabi SK. COMPLICATIONS OF MODIFIED RADICAL NECK DISSECTION TYPE III IN ORAL SQUAMOUS CELL CARCINOMA. Pak Oral Dent J 2014;34(02):
  • 20 Manikantan K, Bang B, Sharan R, Mallick I, Chatterjee S, Arun P. Therapeutic Neck Dissection in Oral Squamous Cell Carcinoma: Is Selective Neck Dissection the Way Ahead?. Kathmandu Univ Med J (KUMJ) 2016; 14 (55) 221-225
  • 21 Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990; 66 (01) 109-113
  • 22 Crile GW. On the surgical treatment of cancer of the head and neck. Transactions Southern Surg Gynecol Assoc 1905; 18: 109-127
  • 23 Rahim DU, Siddiqui AH, Ahmed Z, Marfani MS. Frequency of Cervical Metastasis in Oral Cancer. Pak J Otolaryngol 2013; 29: 80-83
  • 24 Medina JE, Byers RM. Supraomohyoid neck dissection: rationale, indications, and surgical technique. Head Neck 1989; 11 (02) 111-122
  • 25 Spiro JD, Spiro RH, Shah JP, Sessions RB, Strong EW. Critical assessment of supraomohyoid neck dissection. Am J Surg 1988; 156 (04) 286-289
  • 26 McLean T, Kerr SJ, Giddings CEB. Prophylactic dissection of level V in primary mucosal SCC in the clinically N positive neck: A systematic review. Laryngoscope 2017; 127 (09) 2074-2080
  • 27 Iqbal H, Bhatti ABH, Hussain R, Jamshed A. Regional failures after selective neck dissection in previously untreated squamous cell carcinoma of oral cavity. Int J Surg Oncol 2014; 2014: 205715
  • 28 Shin YS, Koh YW, Kim S-H, Choi EC. Selective neck dissection for clinically node-positive oral cavity squamous cell carcinoma. Yonsei Med J 2013; 54 (01) 139-144
  • 29 Pfister DG, Ang K-K, Brizel DM. et al; National Comprehensive Cancer Network. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013; 11 (08) 917-923
  • 30 Gane EM, O'Leary SP, Hatton AL, Panizza BJ, McPhail SM. Neck and upper limb dysfunction in patients following neck dissection: looking beyond the shoulder. Otolaryngol Head Neck Surg 2017; 157 (04) 631-640
  • 31 Andersen PE, Warren F, Spiro J. et al. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg 2002; 128 (10) 1180-1184
  • 32 Feng Z, Li JN, Niu LX, Guo CB. Supraomohyoid neck dissection in the management of oral squamous cell carcinoma: special consideration for skip metastases at level IV or V. J Oral Maxillofac Surg 2014; 72 (06) 1203-1211
  • 33 Chepeha DB, Hoff PT, Taylor RJ, Bradford CR, Teknos TN, Esclamado RM. Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. Laryngoscope 2002; 112 (03) 434-438